PATENT CLAIM ANALYSIS

Application Number: 16098262
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "255050"]

Abstract:
The present invention relates to novel 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

Claim (Index 7):
Compound as defined  claim 1  for use in a method for the treatment and/or prevention of a disease selected from the group consisting of\n acute kidney disease, \n chronic kidney disease, \n diabetic nephropathy, \n acute heart failure, \n chronic heart failure, \n peripheral arterial disease (PAD), \n coronary microvascular dysfunction (CMD), \n Raynaud's syndrome, \n dysmenorrhea, \n cardiorenal syndrome, \n hypervolemic hyponatremia, \n euvolemic hyponatremia, \n liver cirrhosis, \n ascites, \n edema, and \n the syndrome of inadequate ADH secretion (SIADH).

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.68571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16098255', '15581064', '15969222', '13819885', '16098202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8142295455160506
- 35 USC 102 Novelty (BERT): 0.6024878258029037
- Combined Prediction Score: 0.7930553735447359
- Mean Citation Score: 423.403306
- Max Citation Score: 520.59686
- Similarity Product: 474.965893045063

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test